{"id":458325,"date":"2010-03-22T12:43:46","date_gmt":"2010-03-22T16:43:46","guid":{"rendered":"http:\/\/blogs.reuters.com\/james-pethokoukis\/?p=3517"},"modified":"2010-03-22T12:43:46","modified_gmt":"2010-03-22T16:43:46","slug":"15-healthcare-winners-and-losers-in-a-phrase","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/458325","title":{"rendered":"15 healthcare winners and losers, in a phrase"},"content":{"rendered":"<p>1. Obama the Democrat. Achievement of 50-year Dem goal means no 2012 nomination challenge. W<\/p>\n<p>2. Obama the Centrist. Not with an all-Dem bill that has upside-down approval ratings.L<\/p>\n<p>3. Big Pharma. No Canadian drugs, plus they get more generic biotech protection. W<\/p>\n<p>4. Big Insurance. Loads of new regulations plus wimpy mandate that means new customers might not show. L<\/p>\n<p>5. Treasury holders. Tax hikes and spending cuts for coverage expansion rather than Medicare solvency. L<\/p>\n<p>6. 2010 GOP. Loss ensures motivated base for midterms. W<\/p>\n<p>7.Supreme Court. May have to decide constitutionality of politically explosive individual mandate. L<\/p>\n<p>8. Rep. Paul Ryan. Confrontation with Obama cranks up profile. W<\/p>\n<p>9. Majority Leader Steny Hoyer.Speaker Nancy Pelosi not going anywhere, even if a big November loss. L<\/p>\n<p>10. Mitt Romney. Anger over Obamacare could seep into RomneyCare. L<\/p>\n<p>11. Mitt Romney. Expertise in healthcare could boost him in 2012. W<\/p>\n<p>12. Investors. Overall, cap gains taxrates are rising 60 percent. L<\/p>\n<p>13. Government workers. Uncle Sam is going to lots need more to administer this. W<\/p>\n<p>14. Federalism. Top-down health mandate that some states may not be able to afford. L<\/p>\n<p>15. China. More pressure to enhance its own safety net to boost consumption. W (for US, at least)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. Obama the Democrat. Achievement of 50-year Dem goal means no 2012 nomination challenge. W 2. Obama the Centrist. Not with an all-Dem bill that has upside-down approval ratings.L 3. Big Pharma. No Canadian drugs, plus they get more generic biotech protection. W 4. Big Insurance. Loads of new regulations plus wimpy mandate that means [&hellip;]<\/p>\n","protected":false},"author":1063,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-458325","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/458325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1063"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=458325"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/458325\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=458325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=458325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=458325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}